Condition: Opioid-use Disorder · Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
This is a pilot study to evaluate the safety and efficacy of deep brain stimulation (DBS) of the nucleus accumbens (NAc) as adjunctive treatment for treatment-refractory opioid use disorder. This study will include 3 individuals with opioid use disorder and relapsing opioid use despite active participation in a drug addiction treatment program.
This description comes directly from the study's public registry record.
Nestor Tomycz, MD · 412-359-6200 · nestor.tomycz@ahn.org
Donald Whiting, MD · 412-359-6200 · donald.whiting@ahn.org
Always discuss trial participation with your own doctor first.
| AHN Allegheny General Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04354077